Published in Cancer Weekly, February 21st, 2006
"It is another intervention point where one can now attack tumors. It's especially important for endocrine tumors such as those of the breast, prostate, ovary, and pituitary gland," said Bert O'Malley, chair of the Baylor College of Medicine department of molecular and cellular biology. O'Malley is senior author of a report on the research published in the journal Cell.
O'Malley and his colleagues concentrated their efforts on a powerful...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.